You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RTSN Conversion Disclosure
Keller Eric L. · SEC Form 4 · Filed Oct 13, 2026
Conversion
Reported value range
Not reported
Keller Eric L. Chief Executive Officer
RTSN
Transaction date
Oct 13, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed same day
RTSN daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B Convertible Preferred Stock on Common Stock
- Quantity / price
- 31,368 shares
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001213900-26-109160
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$249.6K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Retension Pharmaceuticals, Inc. RTSN | Conversion | Oct 13, 2026 | Not reported |
| Retension Pharmaceuticals, Inc. RTSN | Award | Oct 13, 2026 | $0 |
| Retension Pharmaceuticals, Inc. RTSN | Conversion | Oct 13, 2026 | Not reported |
| Retension Pharmaceuticals, Inc. RTSN | Buy | Oct 13, 2026 | $249.6K |
| Retension Pharmaceuticals, Inc. RTSN | Conversion | Oct 13, 2026 | Not reported |
| Retension Pharmaceuticals, Inc. RTSN Current | Conversion | Oct 13, 2026 | Not reported |